COMMUNIQUÉS West-GlobeNewswire

Culture Biosciences Appoints Chris Williams as Chief Executive Officer
26/09/2024
Former COO of Cytek Biosciences brings extensive bioprocessing experience to drive next phase of growth at Culture Biosciences South San Francisco, CA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Culture Biosciences, a leader in [...]
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update
26/09/2024
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update Financial and business highlights Total H1 2024 incomes of €82.5 million thanks to Company’s new partnerships. New strategic [...]
OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables et fait le point sur ses avancées
26/09/2024
OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables et fait le point sur ses avancées Éléments financiers et business développement Revenus du premier semestre 2024 de 82,5 millions d’euros grâce [...]
Vistin Pharma ASA: Mandatory notification of trade
26/09/2024
Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58% ownership.Saga Pure [...]
Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines
26/09/2024
First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the [...]
Bavarian Nordic Upgrades its Financial Guidance for 2024
26/09/2024
COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) upgrades its financial guidance for 2024. Based on today’s announced mpox vaccine order and additional orders secured, combined with improved [...]
Urteste Expands Development of Innovative Diagnostic Projects
26/09/2024
Urteste Expands Development of Innovative Diagnostic Projects Gdańsk, Poland – 26 SEPTEMBER 2024, 16:00 CET - Urteste S.A. (Warsaw Stock Exchange: URT), a biotechnology company specializing in the development of [...]
Acentra Health Earns Recertification to ISO 9001:2015 Standard for its Quality Management System
26/09/2024
Adherence to rigorous certification standards reinforces Acentra Health’s client-first commitment to delivering maximum value and impact with high quality solutions and services MCLEAN, Va., Sept. 26, 2024 (GLOBE [...]
BioNTX Announces 2024 Tech Transfer Showcase Finalists Pitch Competition at the 2024 iC³ Life Science & Healthcare Innovation Summit
26/09/2024
ARLINGTON, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- BioNTX is pleased to announce the finalists for the 3 rd Annual Tech Transfer Showcase, set for Friday, October 4th, at the 2024 iC³ Life Science & Healthcare [...]
CannaCon Midwest Convenes in Cleveland October 2024
26/09/2024
CLEVELAND, Sept. 26, 2024 (GLOBE NEWSWIRE) -- via CannabisNewsWire (“CNW”) — CannaCon , a first-class conference company producing state-of-the-art B2B events for cannabis businesses, marijuana entrepreneurs, investors [...]
New Research Findings Reveal Employers Who Contribute to HSAs See Double-Digit Growth in Employee Participation
26/09/2024
New HealthEquity research indicates employers who optimize HSA contribution strategies are more directly supporting their employees’ financial well-being DRAPER, Utah, Sept. 26, 2024 (GLOBE NEWSWIRE) -- HealthEquity, [...]
Kaida BioPharma to Present at BioSparkVA Pitch Event
26/09/2024
FORT LAUDERDALE, FL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the “Company”), an early-stage pharma company dedicated to advancing ovarian cancer treatment through innovative drug development, [...]
GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
26/09/2024
SAN FRANCISCO, CALIFORNIA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the [...]
Safety Shot Spins Off Caring Brands Business with Plans to Issue a Dividend to Shareholders
26/09/2024
The Company is Divesting its Wellness Unit to Create Value for Shareholders and to Focus on Commercialization of its Safety Shot Dietary Supplement JUPITER, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Safety Shot , Inc. ( [...]
SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
26/09/2024
The intended selling valuation represents an increase of 47 % from the valuation at the time of SciSparc’s initial investment in MitoCareX Bio TEL AVIV, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: [...]
Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
26/09/2024
Exploring potential partnership and strategic opportunities for the Company’s cellular therapy program in Alzheimer’s disease Highlighting the Company’s cellular therapy contract development and manufacturing business [...]
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
26/09/2024
DALLAS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, is excited to announce the release of its first-ever Education Insights Report. This [...]
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to January 31, 2025
26/09/2024
US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to January 31, 2025. Accordingly, any shares of the [...]
Hapbee Appoints Mr. Abdulla Al Zain to Board of Directors
26/09/2024
Appointment indicates Hapbee’s commitment to expand in the Middle East and globally MONTRÉAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- CNW Telbec/ - Hapbee Technologies, Inc. (TSXV: HAPB ) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" [...]

Pages